Advertisements



Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Oppenheimer Turns Bullish On Seattle Genetics, Says Optimism Fueled By Pipeline Readouts

While recent pullback in Seattle Genetics, Inc’s (NASDAQ: SGEN) shares presents an attractive entry point, there are several pipeline catalysts ahead, according to O.....»»

Category: blogSource: benzingaSep 12th, 2019

Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Vertex CEO says company is seeking to make "transformative" deals

Shares of Vertex Pharmaceuticals Inc. were down 4.3% in trading on Tuesday, the day after the company discussed its deal-making strategy with analysts during its fourth-quarter earnings call. The company said it is considering buying companies wi.....»»

Category: topSource: marketwatchFeb 2nd, 2021

Why Vertex"s Stock Is Trading Higher Today

Vertex Pharmaceuticals (NASDAQ: VRTX) shares are trading higher after Argus Research maintained a Buy rating on the stock and raised its price.....»»

Category: blogSource: benzingaMay 15th, 2020

Baird upgrades Pieris Pharmaceuticals as pipeline updates expected

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 13th, 2020

O-I Glass shares attractive,valuation not rational says Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2020

Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More

Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa......»»

Category: blogSource: 247wallstJan 31st, 2020

JPMorgan upgrades Arena Pharmaceuticals ahead of "catalyst rich" two years

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2020

Vertex Pharma stock rises on earnings, outlook beat

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

Category: topSource: marketwatchJan 30th, 2020

Syros Pharmaceuticals risk/reward balanced ahead of data readouts, says Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 17th, 2020

Raymond James Upgrades iRobot, Sees Positive Catalysts Ahead

There are potential upside catalysts for iRobot Corporation’s (NASDAQ: IRBT) stock and few negative catalysts that could push shares below the $45-$55 range, according to Raymond James. Latest Ratings for IRBT Dat.....»»

Category: blogSource: benzingaJan 16th, 2020

Benzinga"s Top Upgrades, Downgrades For December 26, 2019

Downgrades Cantor Fitzgerald downgraded Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) from Overweight to Neutral. Spectrum Pharmaceuticals shares closed at $8.75 on Tuesday. 0.....»»

Category: blogSource: benzingaDec 26th, 2019

Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 18th, 2019

Zynerba Analyst Says Stock A Buy Ahead Of Zygel Data Release In 2020

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares ended Monday's session nearly 15% higher after Canaccord Genuity said the stock's mid-September sell-off was unjustified.  Latest Ratings for ZYNE .....»»

Category: blogSource: benzingaDec 16th, 2019

Bank Of America Upgrades Thomson Reuters On Accelerating Growth, Attractive Valuation

It’s been a good year for Thomson Reuters Corp (NYSE: TRI), but one Wall Street analyst said Monday there’s even more upside ahead for the stock. Latest Ratin.....»»

Category: blogSource: benzingaNov 11th, 2019

Nomura Upgrades Chewy, Says "Valuation Now More Attractive"

After initially popping as high as $39 per share following its summer IPO, Chewy Inc (NYSE: CHWY) shares are down 14% in the past three months as excitement ove.....»»

Category: blogSource: benzingaSep 23rd, 2019

Square stock heads higher after pair of upgrades

Square Inc. shares have been largely flat in recent months, but a pair of analysts now see better times ahead for the fintech stock. MoffettNath.....»»

Category: topSource: marketwatchSep 3rd, 2019

Methode Electronics shares appear mispriced ahead of earnings, says Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2019

Canopy Growth shares rise premarket after Seaport Global upgrades to buy from neutral

Canopy Growth Corp. shares rose 1.6% in premarket trade Monday, after Seaport Global upgraded the stock to buy from neutral and said it now looks attractive after a steep selloff. Canopy s.....»»

Category: topSource: marketwatchAug 26th, 2019

Deciphera Soars On Positive Readouts For Gastrointestinal Tumor Drug

Shares of thinly traded small-cap biotech Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) are skyrocketing Tuesday morning following a couple of clinical readouts from the company. read more.....»»

Category: blogSource: benzingaAug 13th, 2019